TOKYO, Feb 8, 2023 – (JCN Newswire via SEAPRWire.com) – Fukuoka Prefecture, Commercial Japan Partnership Technologies Corporation (CJPT), and Kyushu Railway Company (JR Kyushu) have …
DOCOMO Conducts World’s First Trial of Transmissive Metasurface on Window to Deliver Indoor Radio Waves to Outdoor Foot of Building
TOKYO, Jan 30, 2023 – (JCN Newswire via SEAPRWire.com) – NTT DOCOMO, INC. announced today that it has succeeded in what it believes to be …
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a …
Zhaoke Ophthalmology Announces 2022 Interim Results
HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical …
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO …
Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans
NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million …
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery
LAUSANNE, Switzerland, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and …
Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022
SEOUL, S.KOREA, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services …
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …